REGENCY

By Freely Filtered - Last Updated: April 22, 2025

Freely Filtered discusses REGENCY, examining the efficacy and safety of obinutuzumab in active lupus nephritis.

Post Tags:lupus nephritis

Related Podcasts

KDIGO ADPKD Guidelines
ADPKD
Metabolic Alkalosis: Chapter 18
Nephrology
NephMadness
hemodialysis
Top Nephrology Stories of 2024
CKD
Introduction to Simple and Mixed Acid-Base Disorders: Chapter 17
Channel Your Enthusiasm
Advertisement
Advertisement
Latest News

Risk-Reducing Surgery Linked to Survival in Young BRCA Carriers

May 20, 2025

Successful HIV Viral Suppression With At-Home Administration

May 20, 2025

Modernization and the Rising Burden of IBD: New Insights From a Global Study

May 19, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |